from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A drug to treat conditions that lead to thrombocytopenia.


Sorry, no etymologies found.


  • The drug, also known by its generic name eltrombopag, is designed to increase platelet counts and reduce or prevent bleeding, and is intended for people who have undergone prior treatment.

    FDA Panel Backs Glaxo Platelet Drug Promacta

  • Ligand partner GlaxoSmithKline announced that it received positive data from ENABLE-1, the first of two Phase III studies examining Promacta eltrombopag in patients with hepatitis C-related thrombocytopenia, and that full data will be released at an upcoming scientific conference.

  • Usual sterapred dose for anthrax prophylaxis: mass eltrombopag treatment or acid of internal anthrax: 400 tendon accidentally every 12 conditions for 60 age case of free center release as a next weapon, the working group on civilian biodefense has suggested that, prescribed on in vitro studies, haze could react discarded for weight prophylaxis or assessment of polyvalent alcohol if amount and erythema are unavailable.


  • The study suggests that drug Promacta (r) (eltrombopag) is safe and effective in treating the blood disorder.

    Medindia Health News

  • Two-thirds received the standard of care with the addition of 50mg of eltrombopag, while the other group received placebo pill.

    Medindia Health News

  • The new trials showed that eltrombopag was effective in raising platelet counts and lowering bleeding in adult with chronic ITP.

    Medindia Health News

  • "Approval in Europe presents an expanded market opportunity for eltrombopag and is an exciting development for L.gand as it continues to validate L.gand's success in contributing to the discovery of novel and important commercial therapies," said John L. Higgins, President and Chief Executive Officer of L.gand Pharmaceuticals.


  • (eltrombopag), a drug discovered in collaboration with GlaxoSmithKline (NYSE: GSK) was recognized as "Best Biotechnology Product" by the Prix Galien USA committee on October 1,

    American Chronicle

  • LGND) face an unknown delay on a decision for Promacta (eltrombopag) for the treatment of chronic idiopathic thrombocytopenic purpura (ITP).

    Healthcare Sector and Stocks Analysis from Seeking Alpha


Log in or sign up to get involved in the conversation. It's quick and easy.